This interpretation of p16 staining in invasive carcinoma is based on the recommendations for head and neck squamous cell carcinoma by the American Society of Clinical Oncology and the College of American Pathologists [26]. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.